Mid-Day Alert 2-19-10






 

Mid-Day Alert for Friday 2-19-10
 
 
 
USOG is up 32% since we recommended it at yesterday’s Mid-Day Alert. And this morning it has traded over double the 10-day-average in volume. 
 
 
 
Percentage Gainer: MEXP
Marine Exploration, Inc., a development stage company, engages in marine treasure hunting expeditions in Colorado and internationally. It involves in the exploration and recovery of deep ocean shipwrecks, as well as in the marketing and sale of recovered artifacts, replicas, merchandise, and media.

****************

Possible Bounce: DCSO
http://finance.yahoo.com/news/Liberty-Analytics-Co-pz-1033058432.html?x=0&.v=1 Laboratories, Inc. is a biotechnology company developing Surfactant Therapies for respiratory diseases. Surfactants are produced naturally in the lungs and are essential for breathing. Discovery Labs’ novel proprietary KL4 Surfactant Technology produces a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant and is being developed in liquid, aerosol or lyophilized formulations

****************
 
 
 
 
 
 
 
 
 
 
 

OTCReporter.com and HotOTCChina.com are owned by Oceanic Consulting, LLC ("Oceanic") and Garden State Resources NJ, LLC ("Garden State"), both of which are New Jersey limited liability corporations (OTCReporter.com and Hot OTCChina.com and its owners, Oceanic and Garden State, and their affiliates, directors and officers and its immediate family members are referred to in our Disclaimer as "OTCR" or "we" or "us" or "our"). Oceanic and Garden State are referred to herein collectively as the "LLC Companies" when the context of the statements pertain to compensation matters, including our "Compensation Disclosure" section that seeks to comply with Section 17(b) of the 1933 act, as amended, which states that any person who disseminates publications or other communications (through interstate commerce) for consideration received or to be received, directly or indirectly, from an issuer,
underwriter, or dealer, must disclose the receipt and amount, whether past or prospective, of such consideration. .

It is imperative that all readers of the above Compensation Disclosure Section click on the link below to carefully review our Disclaimer in its entirety, which contains important information about penny stocks, our operations, the limited nature of the information presented in our publications and various risks attendant to the companies that we profile.
 
 




This message was sent from OTCReporter to Subscriber. It was sent from: OTCReporter.com, P.O. Box 273, Rumson, NJ 07760. You can modify/update your subscription via the link below.

Email Marketing by
iContact - Try It Free!